Skip to main content

For media and investors only

Media

If you are a journalist with a media enquiry, please contact the Moderna UK press office.

Please note that this route is intended for journalists with specific enquiries. We are unable to respond to any non-media enquiries submitted via this route.

Email: UKMedia@modernatx.com

Press releases

3 September 2024

Moderna receives Medicines and Healthcare Products Regulatory (MHRA) authorisation for updated COVID-19 vaccine targeting SARS-COV-2 variant JN.1

10 May 2024

Moderna welcomes the Secretary of State for Health and Social Care to the Moderna Innovation and Technology Centre in Harwell

22 November 2023

Moderna’s clinical laboratories arrive at Harwell Campus

15 September 2023

Moderna receives Medicines and Healthcare Products Regulatory (MHRA) authorisation for updated COVID-19 vaccine

25 April 2023

Construction commences at Moderna Innovation and Technology Centre in the UK

5 March 2023

Moderna selects Harwell science campus in Oxfordshire to develop Moderna Innovation and Technology Centre in the UK

22 December 2022

Moderna Finalizes Strategic Partnership with UK Government

21 June 2022

Moderna Announces Plan to Bring mRNA Innovation to the United Kingdom